Why Is Invitae (NVTA) Stock Down 75% Today?

Medical genetics firm Invitae (NYSE:NVTA) suffered a shocking fall from grace as insider reports point to an upcoming bankruptcy filing. Although the company forwarded a compelling concept — leveraging genetic testing and diagnostics to assess hereditary disease risks — the business model didn’t resonate with customers or investors. As a result, NVTA stock suffered a 75% drop in market value.According to The Wall Street Journal, Invitae’s bankruptcy filing could come within weeks, according to people famili ...